Indianapolis-based pharmaceutical giant Eli Lilly and Company has purchased a 323,930-square-foot industrial building in the ...

Indianapolis-based pharmaceutical giant Eli Lilly and Company has purchased 30.9 acres of vacant land to the north and to the ...

Eli Lilly wants the public to know it’s more ... However, during that time, Lilly has embarked on a greater corporate brand-building effort that it hopes will elevate its reputation as a whole. Lina ...

Ladies and gentlemen, let’s talk about Eli Lilly ... access or saving the corporate bottom line. Bad optics, that’s all I’ll say. For long-term success, Eli Lilly—or any company, for ...

Eli Lilly and Company ... bowel segments (fo Eli Lilly and Company (NYSE: LLY) today announced a $4.5 billion investment to create the Lilly Medicine Foundry, a new center for advanced ...

Powered by its popular GLP-1 weight loss drugs, Eli Lilly's stock (NYSE ... to create an advanced manufacturing and drug development center at its Indiana facility, which comes on the heels ...

I see this as a strategic move on Lilly's end; it seems the company is content taking its time building a ... both Novo Nordisk and Eli Lilly appear to have strong road maps ahead.

Key drugs from Johnson & Johnson and Eli Lilly stand to bolster their respective cases in competitive dermatology markets with new data readouts. J&J evaluated its Tremfya in patients with low ...

Eli Lilly (NYSE:LLY) said that in patients with moderate-to-severe atopic dermatitis who had previously been treated with dupilumab, known by its brand name Dupixent, their Phase 3b study showed ...

Eli Lilly said on Monday it sued three medical spas and online vendors for selling products that claimed to contain tirzepatide, the main ingredient in its popular weight-loss medicine ...

To learn more about how we handle and protect your data, visit our privacy center. Maintaining independence and editorial freedom is essential to our mission of empowering investor success.